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The present study was conducted to determine how long hyperplastic polyps (HPs) and fundic
gland hyperplastic polyps (FGPs) should be endoscopically followed up. Our findings showed
that in the case ofFGPs, yearly endoscopy is not required and it is sufficient to repeat X-ray
and compare films with those obtained in the previous year. In contrast, yearly follow-up by
endoscopy is necessary in the case ofHPs.
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0. INTRODUCTION
Gastric polyps (benign epithelial elevated lesions in
the stomach) are one of the diseases gastroenterol-
ogists most often encounter in daily clinical practice.
They are also often discovered by X-ray in mass
examination.
Discovery of gastric polyps in X-rays conducted
to detect stomach cancer is followed by endoscopy
for more detailed examinations. Even if polyps are
found benign as a result of detailed examinations, it
is recommended at present that patients receive
follow-up examinations one year later. Iflesions are
found in X-rays the next year, detailed examinations
by endoscopy is repeated, resulting in endoscopic
procedures every year.
In order to determine if yearly endoscopic moni-
toring is necessary, we studied the fate of foveolar
type hyperplastic polyps (HPs) and fundic gland
hyperplastic polyps (FGPs), which account for a
great majority of gastric polyps.
1. SUBJECTS
Included in the present study were the following
patients who, undergoing endoscopy in Tokyo
Medical University Hospital in 1994, were histolog-
ically diagnosed as having HPs or FGPs, and who
were subsequently monitored for at least one year:
(1) 95 HP patients (male :female ratio, 1.4 1; mean
age, 61.3) and (2) 84 FGP patients (male:female
ratio, 1.8; mean age, 50.4) (Table I).
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TABLE Classification of subjects
HP FGP
Subjects
No. of cases 95 84
Male female ratio 56 39 1.4 30:54 1.8
Mean age 61.3 50.4
Size of polyps
< 5mm 25(5) 67(10)
< 10mm 41(18) 16(1)
< 15mm 39
< 20mm 21 0
> 20mm 11 0
): Morphological change.
TABLE II Morphological changes
HP FGP
No change 72 (75.8%) [28 M] 73 (86.9%) [34 M]
Increased 16 (16.8%) [52 M] 7 (8.3%) [50 M]
(size or number)
Reduction 7 (7.4%) [54 M] 4 (4.8%) [48 M]
(size or number)
Total 95 (100%) 84 (100%)
]: Average time period of follow-up.
3. RESULTS
Because examinations were conducted by endo-
scopy, the size of polyps could not be accurately
determined. Compared to the size of the cap of the
forceps for biopsy, however, the size of most
hyperplastic polyps was estimated to range between
5 and 10mm, while some seemed to measure 20mm
or more. Most of the FGPs measured 5mm or less.
All FGPs except one which was subjected to
polypectomy (and which measured 15mm) mea-
sured 10mm or less (Table I).
2. METHODS
Endoscopic films were retrospectively reviewed to
determine changes in the morphology and number
ofpolyps during monitoring, whether polypectomy
was conducted, coexistence of dysplastic foci in
polyps, and the presence or absence of tumorous
lesions in other areas.
Biopsy specimens were retrospectively reviewed
to determine the presence or absence ofHelicobacter
pylori (H. pylori) and the degree of inflammatory
cell infiltration. The presence or absence ofH. pylori
was determined using the Hematoxylin-Eosin and
Giemsa staining technique. Inflammatory cell infil-
tration was scored using the updated Sydney system
[1], which evaluates inflammation-related items
based on a 4-grade scale (none, 0; mild, 1; moderate,
2; severe, 3).
3.1. Morphological Changes
Existing polyps increased in size or the number of
polyps increased in 16 of the 95 HP patients
(16.8%), while existing polyps showed reductions
in size or the number of polyps decreased (partly
due to exfoliation) in 7 (7.4%). No morphological
changes were seen in 72 patients (75.8%).
Existing polyps increased in size or the number of
polyps increased in 7 ofthe 84 FGP patients (8.3%),
while existing polyps showed reduction in size or the
number of polyps decreased (partly due to exfolia-
tion) in 4 (4.8%). No morphological changes were
seen in 73 patients (86.9%) (Table II).
Most HPs with morphological changes measured
5-10mm, while most FGPs with morphological
changes measured 5mm or less. All these polyps
measured 10mm, suggesting that the cause of
morphological changes is not related to the sizes of
polyps, but their nature.
These findings suggest that HPs are more liable to
show morphological changes than FGPs.
3.2. Endoscopic Polypectomy
Endoscopic polypectomy was conducted with
respect to 13 lesions in 10 of the 95 HP patients
10.5%). Dysplastic foci were observed in 4 ofthe 13
lesions (30.8%) (Figs. 1-3).
Endoscopic polypectomy was conducted with
respect to only one lesion in ofthe 84FGP patients
(1.2%). No dysplastic foci or cancerous foci were
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FIGURE Case 1. 42-year-old man. A Yamada type-IV
polyp with redness was discovered on the posterior wall of
the upper part of the body of the stomach. Endoscopic find-
ings were those of a typical HP. Endoscopic polypectomy was
conducted.
3.3. Changes after 1994
Endoscopic examinations were carried out in 45 of
the 95 HP patients after 1994. Cancerous foci were
observed in 2 patients, in the monitored polyp in
patient and in other area in patient.
Endoscopic examinations were carried out in 31
of the 84 FGP patients after 1994. Cancerous foci
were observed in no monitored polyps or other areas
in any patient.
3.4. Presence or Absence of H. pylori
Microscopic examinations revealed organisms sus-
pected of being H. pylori in 56 of 95 HP patients
(58.9%) (Figs. 4 and 5) and 27 of the 84 FGP
patients (32.1%). Differences between the two
groups were statistically significant (p--0.001 by
2-test) (Table III).
3.5. Degree of Inflammation
The degree of inflammation was determined by
examining biopsy specimens taken from polyps.
FIGURE 2 Case 1. Histological findings were consistent
with those of an HP in most parts of the polyp.
Among the 95 HP patients, inflammation was
absent in no patient, mild in 3, moderate in 32,
and severe in 9 of 60 with a mean score of 2.6, while
among the 84 FGP patients, it was absent in 0, mild
in 67, moderate in 17, and severe in 0 with a mean
score of 1.2. Differences between the two groups
were significant (p 0.001, U-test) (Table IV).
Findings outlined in Sections 3.4 and 3.5 showed
that the H. pylori infection rate is higher and
inflammatory cell infiltration more marked in HP
patients than in FGP patients.
4. DISCUSSIONS
At present, malignant neoplasms is the No. killer
in Japan. Among malignant neoplasms, stomach62 M. KAWAGUCHI AND T. SAITO
FIGURE 3 Case 1. A dysplastic focus was noted near the
base of the polyp.
cancer is ranked No. 2 formen andNo. forwomen.
About 50,000 persons die of stomach cancer each
year. However, mortality due to stomach cancer has
been declining since 1965 due to a number offactors
such as early discovery and treatment through mass
examination programs. Stomach cancer is discov-
ered in only 0.1-0.2% ofpersons who participate in
mass examinations, so they are not necessarily cost-
effective in detecting stomach cancer patients. Due
to the slow-down of economic growth in recent
years, government subsidies for mass examina-
tions have been reduced. For this reason, various
attempts, such as introduction of the pepsinogen
determination method, have been made in order
to increase efficiency of mass examinations. It is
important to decrease the number of endoscopic
procedures in order to reduce not only the economic
burden but stress on patients as well. In the present
study, therefore, we evaluated if the number of
endoscopic procedures can be reduced in the
monitoring of benign elevated gastric epithelial
lesions (gastric polyps), which can be relatively
easily detected and are in fact detected in a large
number ofpersons by X-rays in mass examinations.
In our facility, gastric polyps are detected in 7.8%
of persons by X-rays in mass examinations. This
detection rate is similar to that in the literature.
Usually, endoscopy is conducted for detailed exam-
inations if lesions are discovered by X-rays. Even
if lesions are found benign as a result of detailed
examinations by endoscopy, it is often repeated the
next year if lesions are detected again by X-rays.
In other words, patients undergo endoscopy once a
year once gastric polyps are discovered by X-rays.
Whether this monitoring is necessary and useful is
questionable because it is well established that FGPs
are not cancerous and that it is extremely rare that
cancer occurs in areas other than FGPs in the same
stomach [2]. In contrast, however, HPs are reported
to be cancerated in some patients [3-5]. Therefore,
applying the same monitoring policy to HPs and
FGPs may be cost-ineffective. In order to give an
answer to this question, we evaluated morphologi-
cal changes in HPs and FGPs and reviewed biopsy
findings in patients with these lesions.
As reported by many authors [4,6], morpholog-
ical changes were seen with bothHPs and FGPs, but
incidence was slightly higher with HPs.
Dysplastic or cancerous foci are often detected in
excised HPs. In the present study, dysplastic foci
were found in 30.8% ofHP lesions, a very high rate
probably partly due to the small number of lesions
examined. In our previous study, dysplastic and
cancerous foci were detected in 5% and 2.5%,
respectively, of endoscopically excised HPs. In a
similar study, Iijima [3] reported the presence of
dysplastic and cancerous foci in 9.2% and 2.9%,
respectively, of HPs and found that dysplastic
lesions were tumorous, suggesting that dysplastic
lesions may be transformed into cancer. These find-
ings suggest thatHPs for whichpolypectomy is indi-
cated have cancerization potential. Histologically,HOW TO FOLLOW THE GASTRIC POLYPS 63
FIGURE 4 The foveolar epithelium shows hyperplasia. Marked infiltration of lymphocytes, plasmacytes, and neutrophils is
seen in the interstitium. Proliferation of capillaries is also observed. It showed a typical histological finding of HP (HE 200).
FIGURE 5 Mucus is found in the surface layer of this HP. H. pylori is found in the mucus and adhered to the surperficial
epithelium (Giemsa x400).64 M. KAWAGUCHI AND T. SAITO
TABLE III Positive ratio of H. pylori
No. of cases No. of positive cases Positive ratio*
HP 95 56 58.9
FGP 84 27 32.1
*p 0.001 (x2-test).
TABLE IV Degree of inflammation
Score None Mild Moderate Severe Average score*
0 2 3
HP (n 95) 0 3 32 60 2.6
FGP (n 84) 0 67 17 0 1.2
*p 0.001 (U-test).
FIGURE 7 Case 2. The other polyps were discovered in the
greater curvature in the middle of the body of the stomach.
All polyps showed redness and were endoscopically diagnosed
as HPs. All 3 polyps were endoscopically excised.
FIGURE 6 Case 2. A 60-year-old woman. Three polyps
were discovered, 2 in the greater curvature in the lower part
of the body of the stomach.
the lesion in case 2 (Figs. 6-9) included in the present
study showed an HP element at the base and a
cancerous focus at the apex, suggesting that an HP
has cancerated in this case.
We have not seen any dysplastic or cancerous
foci in FGPs in our patients. Our literature retrieval
also failed to discover any report of canceration
of FGPs.
Cancerous or tumorous lesions were detected in
areas other than polyps in 3 HP patients (3.2%) but
in no FGP patient. Furthermore, monitoring of
patients included in the present study revealed onset
ofcarcinoma or adenoma in 2 HP patients but in no
FGP patient. These findings suggest that HPs
themselves and the gastric mucosa with HPs are
more likely to cancerate than FGPs and the gastric
mucosa with FGPs.
The exact mechanism of stomach cancer is un-
known, but injury ofcellDNA is essential. Recently,
the relationship between H. pylori infection and
stomach cancer has been highlighted. The WHO
IARC study provided epidemiological evidence that
H. pylori infection can be a cause ofstomach cancer.
A recent study in Mongolian Gerbil also showed
that H. pylori infection alone can cause stomach
cancer [7,8]. The role ofH. pylori in the development
ofstomach cancer has not yet been well understood
[9], but there is no doubt that inflammation caused
by H. pylori infection contributes to it. Neutrophilic
elastase and other free radicals generated by inflam-
mation caused by H. pylori infections react with
ammonia produced by H. pylori’s urease, resultingHOW TO FOLLOW THE GASTRIC POLYPS 65
FIGURE 8 Case 2. Of the 2 polyps in the lower part of the body of the stomach, the one on the anterior wall showed well
differentiated tubular adenocarcinoma in an area from the middle to the apex.
in the formation of monochloramine, which injure
DNA of gastric epithelial cells [10,11].
Incidence ofH. pylori infections is closely related
to the ages of patients. In Japan, incidence of
positive serum antibody is comparable in patients
in their 50s and those in their 60s. Therefore, the
differences in the incidence of H. pylori positive
rate between patients with HP and those with FGP
are thought to be lesion-specific. For this reason, we
evaluated the relationship between H. pylori and
inflammatory cell infiltration.
We determined the presence or absence of
H. pylori in HPs and FGPs and the degree of
inflammatory cell infiltration and found that HPs
are more often infected by H. pylori and show more
marked inflammation than FGPs. This finding
seemed to offer a clue to the answer why HPs and
the background gastric mucosa with it show great
malignant potential.
Endoscopic examinations of the background
gastric mucosa with HPs and FGPs show that
atrophic changes are marked in the presence of
HPs, while the gastric mucosa is almost normal or
free from atrophic changes in the presence ofFGPs
[12]. This difference is also thought to be due to
lower incidence of H. pylori infections and milder
inflammation in the presence of FGPs.
All these findings suggest that yearly endoscopic
monitoring is unnecessary in FGP patients, but our
data is not sufficient to establish the appropriate
monitoring interval for these patients. In addition,
during the monitoring of one FGP patient in the
past, we observed the disappearance of an FGP
which was followed by the onset ofan IIa-type early
stomach cancer at another site [13]. A similar event
was also reported in some patients. Therefore, FGPs
do need monitoring. The question is how often and
how. At this stage, we would recommend that X-
rays be repeated once a year to compare films with
those of the previous year and that endoscopy be
repeated for detailed examinations if any change is
observed.
HPs need to be endoscopically examined once
a year because they have malignant potential as66 M. KAWAGUCHI AND T. SAITO
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